Evaluation of sex inequity in lung-cancer-specific survival
DOI:
https://doi.org/10.2340/1651-226X.2024.27572Keywords:
lung-cancer-specific survival, sex, curative treatment, palliative treatmentAbstract
Background: Whether sex is an independent prognostic factor in lung cancer survival is the subject of ongoing debate. Both large national registries and single hospital studies have shown conflicting findings. In this study, we explore the impact of sex on lung-cancer-specific survival in an unselected population that is well-characterized with respect to stage and other covariates.
Material and methods: All patients diagnosed with lung cancer at a single hospital serving a whole and defined region in Southern Norway during the 10 years 2007–2016 were included. Follow-up data were available for at least 56 months for all patients. Analyses were adjusted for stage, treatment, performance status, smoking, age, histology, epidermal growth factor receptor/anaplastic lymphoma kinase/immunotherapy treatment and period. Differences in lung-cancer-specific survival by sex were explored using restricted mean survival times (RMST).
Results: Of the 1,261 patients diagnosed with lung cancer, 596 (47%) were females and 665 (53%) males, with mean ages of 68.5 and 69.5 years, respectively. The observed 5-year lung-cancer-specific survival rate was 27.4% (95% CI 23.7, 31.2) in females and 21.4% (95% CI 18.2, 24.8) in males. However, after adjustment for covariates, no significant differences by sex were observed. The 5-year RMST was 0.9 months shorter (95% CI −2.1, 0.31, p = 0.26) in males compared to females.
Interpretation: In this cohort, sex was not associated with a difference in lung-cancer-specific survival after adjusting for clinical and biological factors. Imbalance in stage at diagnosis was the main contributor to the observed difference in lung-cancer-specific survival by sex.
Downloads
References
Lu T, Yang X, Huang Y, et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res. 2019;11:943–53.
https://doi.org/10.2147/CMAR.S187317 DOI: https://doi.org/10.2147/CMAR.S187317
Cancer Registry of Norway. Cancer in Norway 2021 – cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway; 2022.
Cancer Research UK [Internet]. 2021 [cited 23-12-2023]. Available from: https://www.cancerresearchuk.org/sites/default/files/cstream-node/surv_5yr_lung.pdf
DLCR. Yearly report lung cancer 2019–20 [Internet]. 2021 [cited 23-12-2023]. Available from: https://www.lungecancer.dk/wp-content/uploads/2021/10/Årsrapport-20192020_netudgave.pdf
Sagerup CM, Småstuen M, Johannesen TB, et al. Sex-specific trends in lung cancer inci-dence and survival: a population study of 40,118 cases. Thorax. 2011;66(4):301–7.
https://doi.org/10.1136/thx.2010.151621 DOI: https://doi.org/10.1136/thx.2010.151621
Pitz MW, Musto G, Navaratnam S. Sex as an independent prognostic factor in a populat-ion-based non-small cell lung cancer cohort. Can Respir J. 2013;20(1):30–4.
https://doi.org/10.1155/2013/618691 DOI: https://doi.org/10.1155/2013/618691
Radkiewicz C, Dickman PW, Johansson ALV, et al. Sex and survival in non-small cell lung cancer: a nationwide cohort study. PLoS One. 2019;14(6):e0219206.
https://doi.org/10.1371/journal.pone.0219206 DOI: https://doi.org/10.1371/journal.pone.0219206
Barquín M, Calvo V, García-García F, et al. Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate esti-mation. Cancer Epidemiol. 2020;67:101737.
https://doi.org/10.1016/j.canep.2020.101737 DOI: https://doi.org/10.1016/j.canep.2020.101737
Bugge A, Kongerud J, Brunborg C, et al. Gender-specific survival after surgical resection for early stage non-small cell lung cancer. Acta Oncol. 2017;56(3):448–54.
https://doi.org/10.1080/0284186X.2016.1253862 DOI: https://doi.org/10.1080/0284186X.2016.1253862
Franceschini JP, Jamnik S, Santoro IL. Survival in a cohort of patients with lung cancer: the role of age and gender in prognosis. J Bras Pneumol. 2017;43(6):431–6.
https://doi.org/10.1590/s1806-37562016000000298 DOI: https://doi.org/10.1590/s1806-37562016000000298
Foeglé J, Hédelin G, Lebitasy MP, et al. Specific features of non-small cell lung cancer in women: a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997. J Thorac Oncol. 2007;2(6): 466–74.
https://doi.org/10.1097/01.JTO.0000275340.39960.25 DOI: https://doi.org/10.1097/01.JTO.0000275340.39960.25
Wisnivesky JP, Halm EA. Sex differences in lung cancer survival: do tumors behave differently in elderly women? J Clin Oncol. 2007;25(13):1705–12.
https://doi.org/10.1200/JCO.2006.08.1455 DOI: https://doi.org/10.1200/JCO.2006.08.1455
Chang JW, Asamura H, Kawachi R, et al. Gender difference in survival of resected non-small cell lung cancer: histology-related phenomenon? J Thorac Cardiovasc Surg. 2009;137(4):807–12.
https://doi.org/10.1016/j.jtcvs.2008.09.026 DOI: https://doi.org/10.1016/j.jtcvs.2008.09.026
Wainer Z, Wright GM, Gough K, et al. Sex-dependent staging in non-small-cell lung can-cer; analysis of the effect of sex differences in the eighth edition of the tumor, node, metastases staging system. Clin Lung Cancer. 2018;19(6):e933–44.
https://doi.org/10.1016/j.cllc.2018.08.004 DOI: https://doi.org/10.1016/j.cllc.2018.08.004
Jubelirer SJ, Varela NL, Welch CA, et al. Does sex make a difference in survival of patients undergoing resection for early stage non-small cell lung cancer (NSCLC)? W V Med J. 2009;105(4):18–22.
Båtevik R, Grong K, Segadal L, et al. The female gender has a positive effect on survival in-dependent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years. Lung Cancer. 2005;47(2):173–81.
https://doi.org/10.1016/j.lungcan.2004.08.014 DOI: https://doi.org/10.1016/j.lungcan.2004.08.014
Sachs E, Sartipy U, Jackson V. Sex and survival after surgery for lung cancer: a Swedish nationwide cohort. Chest. 2021;159(5):2029–39.
https://doi.org/10.1016/j.chest.2020.11.010 DOI: https://doi.org/10.1016/j.chest.2020.11.010
Wang Z, Mo M, Zhou C, et al. Time-varying effect of sex on prognosis of lung adenocar-cinoma surgical patients in China. Thorac Cancer. 2021;12(11):1699–707.
https://doi.org/10.1111/1759-7714.13959 DOI: https://doi.org/10.1111/1759-7714.13959
Kim DH, Uno H, Wei LJ. Restricted mean survival time as a measure to interpret clinical trial results. JAMA Cardiol. 2017;2(11):1179–80.
https://doi.org/10.1001/jamacardio.2017.2922 DOI: https://doi.org/10.1001/jamacardio.2017.2922
Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata J. 2009;9(2):265–90.
https://doi.org/10.1177/1536867X0900900206 DOI: https://doi.org/10.1177/1536867X0900900206
Yu XQ, Yap ML, Cheng ES, et al. Evaluating prognostic factors for sex differences in lung cancer survival: findings from a large Australian cohort. J Thorac Oncol. 2022;17(5):688–99.
https://doi.org/10.1016/j.jtho.2022.01.016 DOI: https://doi.org/10.1016/j.jtho.2022.01.016
Ek S. Gender differences in health information behaviour: a Finnish population-based survey. Health Promot Int. 2015;30(3):736–45.
https://doi.org/10.1093/heapro/dat063 DOI: https://doi.org/10.1093/heapro/dat063
Rana RH, Alam F, Alam K, Gow J. Gender-specific differences in care-seeking behaviour among lung cancer patients: a systematic review. J Cancer Res Clin Oncol. 2020;146(5):1169–96.
https://doi.org/10.1007/s00432-020-03197-8 DOI: https://doi.org/10.1007/s00432-020-03197-8
Hanagiri T, Sugio K, Mizukami M, et al. Postoperative prognosis in patients with non-small cell lung cancer according to the method of initial detection. J Thorac Oncol. 2007;2(10):907–11.
https://doi.org/10.1097/JTO.0b013e318156079c DOI: https://doi.org/10.1097/JTO.0b013e318156079c
Bertakis KD, Azari R, Helms LJ, et al. Gender differences in the utilization of health care services. J Fam Pract. 2000;49(2):147–52.
Hansen AH, Halvorsen PA, Ringberg U, et al. Socio-economic inequalities in health care utilisation in Norway: a population based cross-sectional survey. BMC Health Serv Res. 2012;12(1):336.
https://doi.org/10.1186/1472-6963-12-336 DOI: https://doi.org/10.1186/1472-6963-12-336
Costa GJ, Silva GTD, Ferreira CG, et al. Brazilian women with lung cancer have a higher overall survival than their male equivalents: a cohort study. Clin Lung Cancer. 2021;22(3):e313–19.
https://doi.org/10.1016/j.cllc.2020.05.022 DOI: https://doi.org/10.1016/j.cllc.2020.05.022
Fu JB, Kau TY, Severson RK, et al. Lung cancer in women: analysis of the national surveillance, epidemiology, and end results database. Chest. 2005;127(3):768–77.
https://doi.org/10.1378/chest.127.3.768 DOI: https://doi.org/10.1378/chest.127.3.768
Miksad RA, Abernethy AP. Harnessing the power of real-world evidence (RWE): a checklist to ensure regulatory-grade data quality. Clin Pharmacol Ther. 2018;103(2):202–5.
https://doi.org/10.1002/cpt.946 DOI: https://doi.org/10.1002/cpt.946
Gender equality by country [Internet]. 2022 [cited 23-12-2023]. Available from: https://worldpopulationreview.com/country-rankings/gender-equality-by-country
Kawaguchi T, Takada M, Kubo A, et al. Performance status and smoking status are inde-pendent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC. J Thorac Oncol. 2010;5(5):620–30.
https://doi.org/10.1097/JTO.0b013e3181d2dcd9 DOI: https://doi.org/10.1097/JTO.0b013e3181d2dcd9
Ball D, Thursfield V, Irving L, et al. Evaluation of the simplified comorbidity score (colinet) as a prognostic indicator for patients with lung cancer: a cancer registry study. Lung Cancer. 2013;82(2):358–61.
https://doi.org/10.1016/j.lungcan.2013.08.011 DOI: https://doi.org/10.1016/j.lungcan.2013.08.011
Statistics Norway. Percentage daily smokers 1973–2021 [Internet]. 2022 [cited 23-12-2023]. Available from: https://www.ssb.no/en/royk
Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer. Ann Glob Health. 2019;85(1):8.
https://doi.org/10.5334/aogh.2419 DOI: https://doi.org/10.5334/aogh.2419
Fenchel K, Sellmann L, Dempke WC. Overall survival in non-small cell lung cancer-what is clinically meaningful? Transl Lung Cancer Res. 2016;5(1):115–19.
https://doi.org/10.21037/tlcr.2016.07.01 DOI: https://doi.org/10.21037/tlcr.2016.07.01
Izumi M, Suzumura T, Ogawa K, et al. Differences in molecular epidemiology of lung can-cer among ethnicities (Asian vs. Caucasian). J Thorac Dis. 2020;12(7):3776–84.
https://doi.org/10.21037/jtd.2019.08.61 DOI: https://doi.org/10.21037/jtd.2019.08.61
Published
How to Cite
License
Copyright (c) 2023 Dan Lærum, Trond-Eirik Strand, Odd Terje Brustugun, Frode Gallefoss, Ragnhild Falk, Michael T. Durheim, Lars Fjellbirkeland
This work is licensed under a Creative Commons Attribution 4.0 International License.
